Cargando…
Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, int...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843934/ https://www.ncbi.nlm.nih.gov/pubmed/24348379 http://dx.doi.org/10.1159/000356469 |
_version_ | 1782293117294084096 |
---|---|
author | Dolenc-Voljč, M. Jurčić, V. Hočevar, A. Tomšič, M. |
author_facet | Dolenc-Voljč, M. Jurčić, V. Hočevar, A. Tomšič, M. |
author_sort | Dolenc-Voljč, M. |
collection | PubMed |
description | Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, intravenous immunoglobulin (IVIg) appears to be the therapy of choice for scleromyxedema. Treatment experiences in atypical manifestations with mucinous nodules are limited to sporadic reports. We report the case of male patient with atypical scleromyxedema without underlying paraproteinemia, presenting with generalized papular and sclerodermoid skin eruption and multiple nodular mucinous lesions on the fingers and face as well as on the eyelids, and associated systemic symptoms. Complete regression of all cutaneous lesions and extracutaneous symptoms with sustained remission was achieved by combined treatment with thalidomide and IVIg. |
format | Online Article Text |
id | pubmed-3843934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-38439342013-12-12 Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin Dolenc-Voljč, M. Jurčić, V. Hočevar, A. Tomšič, M. Case Rep Dermatol Published online: November, 2013 Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations. An atypical clinical presentation with cutaneous and subcutaneous nodules has been reported rarely. In recent years, intravenous immunoglobulin (IVIg) appears to be the therapy of choice for scleromyxedema. Treatment experiences in atypical manifestations with mucinous nodules are limited to sporadic reports. We report the case of male patient with atypical scleromyxedema without underlying paraproteinemia, presenting with generalized papular and sclerodermoid skin eruption and multiple nodular mucinous lesions on the fingers and face as well as on the eyelids, and associated systemic symptoms. Complete regression of all cutaneous lesions and extracutaneous symptoms with sustained remission was achieved by combined treatment with thalidomide and IVIg. S. Karger AG 2013-11-02 /pmc/articles/PMC3843934/ /pubmed/24348379 http://dx.doi.org/10.1159/000356469 Text en Copyright © 2013 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published online: November, 2013 Dolenc-Voljč, M. Jurčić, V. Hočevar, A. Tomšič, M. Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin |
title | Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin |
title_full | Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin |
title_fullStr | Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin |
title_full_unstemmed | Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin |
title_short | Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin |
title_sort | scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin |
topic | Published online: November, 2013 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843934/ https://www.ncbi.nlm.nih.gov/pubmed/24348379 http://dx.doi.org/10.1159/000356469 |
work_keys_str_mv | AT dolencvoljcm scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin AT jurcicv scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin AT hocevara scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin AT tomsicm scleromyxedemawithsubcutaneousnodulessuccessfultreatmentwiththalidomideandintravenousimmunoglobulin |